Accrued Milestones. If a research milestone for a Milestone Target under Section 7.3 above is achieved with respect to such Milestone Target, or a development milestone for a Milestone Compound under Section 7.4.1 above is achieved with respect to such Milestone Compound, in each case before a prior research milestone under Section 7.3 or a prior development milestone under Section 7.4.1 for such Milestone Target or Milestone Compound, respectively, then the earlier milestone payments shall then also be due with respect to such Milestone Target or Milestone Compound, as the case may be.
Accrued Milestones. If a development milestone for a Licensed Product under Section 6.2.1 above is achieved with respect to such Licensed Product before a prior development milestone under Section 6.2.1 for such Licensed Product, then the earlier milestone payments shall then also be due with respect to such Licensed Product.
Accrued Milestones. If a research milestone for a Milestone Target under Section 7.3 above is achieved with respect to such Milestone Target, or a development milestone for a Milestone Compound under Section 7.4.1 above is achieved with respect to such { * } = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. THE NOTATION “[RESERVED]” IS ORIGINAL, IS CURRENTLY IN THE DOCUMENT AND DOES NOT REFLECT INFORMATION REDACTED PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Milestone Compound, in each case before a prior research milestone under Section 7.3 or a prior development milestone under Section 7.4.1 for such Milestone Target or Milestone Compound, respectively, then the earlier milestone payments shall then also be due with respect to such Milestone Target or Milestone Compound, as the case may be.
Accrued Milestones. If a subsequent milestone under Section 6.4 or 6.5 above is achieved for a Product before a prior milestone under Section 6.4 or 6.5 for such Product, then payment for such prior milestone(s), when applicable in accordance with Section 6.4 or 6.5, shall be due at the time of the payment for such subsequent milestone with respect to such Product. For the purposes of this Section 6.6.2, “subsequent” and “prior” milestones shall refer to the numerical order of the milestones, as indicated next to such milestone in Section 6.4 above.
Accrued Milestones. If any of the development milestones 2-7 for a Licensed Product under Section 6.2.1(b) above is achieved with respect to such Licensed Product before development milestone 1 under Section 6.2.1(b) for such Licensed Product, then the milestone payment associated with development milestone 1 shall then also be due with respect to such Licensed Product upon the first achievement of any of milestones 2-7. Additionally, if any of the development milestones 5-7 for a Licensed Product is achieved with respect to such Licensed Product before the corresponding development milestone 2-4 for such Licensed Product in the same territory (meaning, as applicable, the U.S., EMEA, or Japan), then the applicable milestone payment associated with that development milestone 2-4 for that territory shall also be due with respect to such Licensed Product upon the achievement of such development milestone 5-7. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.
Accrued Milestones. If a subsequent research milestone for a target under Section 5.2 above, or a subsequent development milestone for a Licensed Compound under Section 5.3 above, is achieved with respect to such target or Licensed Compound (respectively) before a prior research milestone listed under Section 5.2 or development milestone listed under Section 5.3 for such target or Licensed Compound, then the earlier milestone payments shall then be due with respect to such target or Licensed Compound, as the case may be. For such purposes, “subsequent” and “prior” shall refer to the numerical order of such milestone, as indicated next to such milestone in Sections 5.2 and 5.3 above.
Accrued Milestones. If a research milestone for a Target under Section 5.4.1 above, or a development milestone for a Collaboration Compound under Section 5.5.1 above, is achieved with respect to such Target or Collaboration Compound (respectively) in a territory before a prior research milestone under Section 5.4.1 or a prior development milestone under Section 5.5.1 for such Target or Collaboration Compound in such territory, then the earlier milestone payments in such territory shall then be due with respect to such Target or Collaboration Compound, as the case may be. [*] Certain information on this page has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Accrued Milestones. If a research milestone for a PCC under Section 5.2 above, or a development milestone for a Program Compound under Section 5.3 above, is achieved with respect to such PCC or Program Compound (respectively) in a territory before a prior research milestone under Section 5.2 or a prior development milestone under Section 5.3 for such PCC or Program Compound in such territory, then the earlier milestone payments under Section 5.2 and 5.3 in such territory shall then be due with respect to such PCC or Program Compound, as the case may be. For such purposes, “subsequent” and “prior” shall refer to the numerical order of such milestone, as indicated next to such milestone in Sections 5.2 and 5.3 above; provided, that for the purposes of this Section 5.4.3, (i) milestone 5 under Section 5.2 above shall not be so deemed “prior” to milestone 6 thereunder, and (ii) milestones 4 and 6 under Section 5.3 above shall not be so deemed “prior” to milestones 5 and 7 thereunder, and vice versa.
Accrued Milestones. If a research milestone for a Target or Development Candidate under Section 5.2.2 above, or a development milestone for a Licensed Compound under Section 5.3.1 above, is achieved with respect to such Target, Development Candidate or Licensed Compound (respectively) in a territory before a prior research milestone under Section 5.2.2 or a prior development milestone under Section 5.3.1 for such Target, Development Candidate or Licensed Compound in such territory, then the earlier milestone payments under Section 5.2.2 and 5.3.1 in such territory shall then be due with respect to such Target, Development Candidate or Licensed Compound, as the case may be. For such purposes, “subsequent” and “prior” shall refer to the numerical order of such milestone, as indicated next to such milestone in Sections 5.2.2 and 5.3.1 above; provided, that milestones 4 and 6 under Section 5.3.1 above shall not be so deemed “prior” to milestones 5 and 7, and vice versa.
Accrued Milestones. If any of the development milestones 2-7 for a Licensed Product under Section 6.2.1(b) above is achieved with respect to such Licensed Product before development milestone 1 under Section 6.2.1(b) for such Licensed Product, then the milestone payment associated with development milestone 1 shall then also be due with respect to such Licensed Product upon the first achievement of any of milestones 2-7. Additionally, if any of the development milestones 5-7 for a Licensed Product is achieved with respect to such Licensed Product before the corresponding development milestone 2-4 for such Licensed Product in the same territory (meaning, as applicable, the U.S., EMEA, or Japan), then the applicable milestone payment associated with that development milestone 2-4 for that territory shall also be due with respect to such Licensed Product upon the achievement of such development milestone 5-7.
